Neurotransmitter release during deep brain stimulation

Osama A. Abulseoud, Emily J. Knight, Kendall H Lee

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Deep brain stimulation (DBS) is currently under investigation for treatment of a number of psychiatric indications, including obsessive–compulsive disorder, treatment-resistant depression, and Tourette’s syndrome. Despite its clinical efficacy, the mechanism of action of DBS is incompletely understood. Contrary to the previously proposed mechanism of local inhibition of neural elements at the stimulation site, recent studies have argued that DBS may also cause excitation of efferent target neurons and subsequent changes in neural network activity and neurotransmitter release at various nodes within the neural network. However, the necessary link between symptom change and a corresponding change in neurotransmitters has yet to be firmly established and will be essential to advance our understanding of psychiatric neurobiology. In this chapter, we briefly review the growing scientific evidence in regard to neurotransmitter release as a possible mechanism of action of DBS and the potential impact on neuropsychiatric applications.

Original languageEnglish (US)
Title of host publicationDeep Brain Stimulation: A New Frontier in Psychiatry
PublisherSpringer Berlin Heidelberg
Pages193-204
Number of pages12
ISBN (Print)9783642309915, 9783642309908
DOIs
StatePublished - Jan 1 2012

Fingerprint

Deep Brain Stimulation
Neurotransmitter Agents
Psychiatry
Neural Inhibition
Efferent Neurons
Treatment-Resistant Depressive Disorder
Tourette Syndrome
Neurobiology
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Abulseoud, O. A., Knight, E. J., & Lee, K. H. (2012). Neurotransmitter release during deep brain stimulation. In Deep Brain Stimulation: A New Frontier in Psychiatry (pp. 193-204). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-30991-5_18

Neurotransmitter release during deep brain stimulation. / Abulseoud, Osama A.; Knight, Emily J.; Lee, Kendall H.

Deep Brain Stimulation: A New Frontier in Psychiatry. Springer Berlin Heidelberg, 2012. p. 193-204.

Research output: Chapter in Book/Report/Conference proceedingChapter

Abulseoud, OA, Knight, EJ & Lee, KH 2012, Neurotransmitter release during deep brain stimulation. in Deep Brain Stimulation: A New Frontier in Psychiatry. Springer Berlin Heidelberg, pp. 193-204. https://doi.org/10.1007/978-3-642-30991-5_18
Abulseoud OA, Knight EJ, Lee KH. Neurotransmitter release during deep brain stimulation. In Deep Brain Stimulation: A New Frontier in Psychiatry. Springer Berlin Heidelberg. 2012. p. 193-204 https://doi.org/10.1007/978-3-642-30991-5_18
Abulseoud, Osama A. ; Knight, Emily J. ; Lee, Kendall H. / Neurotransmitter release during deep brain stimulation. Deep Brain Stimulation: A New Frontier in Psychiatry. Springer Berlin Heidelberg, 2012. pp. 193-204
@inbook{3d914c53fa26426cb41c220cbf163643,
title = "Neurotransmitter release during deep brain stimulation",
abstract = "Deep brain stimulation (DBS) is currently under investigation for treatment of a number of psychiatric indications, including obsessive–compulsive disorder, treatment-resistant depression, and Tourette’s syndrome. Despite its clinical efficacy, the mechanism of action of DBS is incompletely understood. Contrary to the previously proposed mechanism of local inhibition of neural elements at the stimulation site, recent studies have argued that DBS may also cause excitation of efferent target neurons and subsequent changes in neural network activity and neurotransmitter release at various nodes within the neural network. However, the necessary link between symptom change and a corresponding change in neurotransmitters has yet to be firmly established and will be essential to advance our understanding of psychiatric neurobiology. In this chapter, we briefly review the growing scientific evidence in regard to neurotransmitter release as a possible mechanism of action of DBS and the potential impact on neuropsychiatric applications.",
author = "Abulseoud, {Osama A.} and Knight, {Emily J.} and Lee, {Kendall H}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-3-642-30991-5_18",
language = "English (US)",
isbn = "9783642309915",
pages = "193--204",
booktitle = "Deep Brain Stimulation: A New Frontier in Psychiatry",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Neurotransmitter release during deep brain stimulation

AU - Abulseoud, Osama A.

AU - Knight, Emily J.

AU - Lee, Kendall H

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Deep brain stimulation (DBS) is currently under investigation for treatment of a number of psychiatric indications, including obsessive–compulsive disorder, treatment-resistant depression, and Tourette’s syndrome. Despite its clinical efficacy, the mechanism of action of DBS is incompletely understood. Contrary to the previously proposed mechanism of local inhibition of neural elements at the stimulation site, recent studies have argued that DBS may also cause excitation of efferent target neurons and subsequent changes in neural network activity and neurotransmitter release at various nodes within the neural network. However, the necessary link between symptom change and a corresponding change in neurotransmitters has yet to be firmly established and will be essential to advance our understanding of psychiatric neurobiology. In this chapter, we briefly review the growing scientific evidence in regard to neurotransmitter release as a possible mechanism of action of DBS and the potential impact on neuropsychiatric applications.

AB - Deep brain stimulation (DBS) is currently under investigation for treatment of a number of psychiatric indications, including obsessive–compulsive disorder, treatment-resistant depression, and Tourette’s syndrome. Despite its clinical efficacy, the mechanism of action of DBS is incompletely understood. Contrary to the previously proposed mechanism of local inhibition of neural elements at the stimulation site, recent studies have argued that DBS may also cause excitation of efferent target neurons and subsequent changes in neural network activity and neurotransmitter release at various nodes within the neural network. However, the necessary link between symptom change and a corresponding change in neurotransmitters has yet to be firmly established and will be essential to advance our understanding of psychiatric neurobiology. In this chapter, we briefly review the growing scientific evidence in regard to neurotransmitter release as a possible mechanism of action of DBS and the potential impact on neuropsychiatric applications.

UR - http://www.scopus.com/inward/record.url?scp=84954590341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954590341&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-30991-5_18

DO - 10.1007/978-3-642-30991-5_18

M3 - Chapter

AN - SCOPUS:84954590341

SN - 9783642309915

SN - 9783642309908

SP - 193

EP - 204

BT - Deep Brain Stimulation: A New Frontier in Psychiatry

PB - Springer Berlin Heidelberg

ER -